For the updated or exact information, you should check edge.pse.com.ph or their official website.
1.
Company Information
|
|||||
Company Name
|
Philab Holdings Corp. (DNA)
|
||||
Sector
|
Small, Medium & Emerging Board
|
Incorporation Date
|
Nov 21, 2000
|
||
Subsector
|
Small, Medium & Emerging Board
|
Number of employees
|
(Group Total)
|
||
Board of Directors
|
Chairman: Jun Tsusaka, CEO: Hector Thomas A. Navasero
|
||||
Website / E-mail
|
alterracapital@gmail.com
|
||||
2.
Stock Information
|
|||||
Total Assets
|
2,069,897,504
|
Market Capitalization
|
8,826,541,536.80
|
||
Total Liabilities
|
1,697,686,859
|
Outstanding Shares
|
2,062,276,060
|
||
Retained Earnings
|
-162,224,316
|
Listed Shares
|
62,276,060
|
||
Listing Date
|
Sep 03, 2009
|
Issued Shares
|
2,062,276,060
|
||
Board Lot
|
1,000
|
Free Float Level (%)
|
14.11%
|
||
Par Value
|
0.25
|
Foreign Ownership Limit
|
100%
|
||
3.
Major Stock Holders (common shares)
|
|||||
Hector Thomas A. Navasero
|
83.83%
|
||||
4.
Company Descriptions and Business Development
|
|||||
Notes
1. Sylvia A. Navasero is the mother of Navasero.
|
|||||
Overview
It was incorporated as a software company under the
name of iRipple, Inc and changed the purpose to holding company under the
name of Alterra Capital Partners, Inc. In 2016, Hector Thomas A. Navasero
acquired the controlling shares and changed it to DNA for the backdoor
listing of Philab Industries Inc. (“Philab”). The acquisition of Philab
Industries, Inc by Philab Holdings Corp. (DNA) is not yet completed.
Business
It doesn’t have commercial businesses for now. Since
the acquisition is not yet completed, Philab is still a separate company.
Philab has been engaged in serving industries in various sectors such as
Health care, Pharmaceutical, Education and Research for more than 58 years.
Major customers are government departments such as DOH, DOST and DepEd.
PHILAB aims to become one of the market leaders in Genomics.
Business
Development
2017: It
announced that it will acquire 67% of pharmaceutical firm Sydenham
Laboratories Inc. (SLI). SLI is the country’s only manufacturer of hormone
based drugs and has over 300 certificates of product registration.
Subsidiaries /
Associates / Affiliates / Joint Ventures
MedX Pte. Ltd. (“MedX”, 100%), a Singaporean Company, is for the
future business.
|
|||||